Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.4K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.4K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

343
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
343
Cancer Survival Analysis01:21

Cancer Survival Analysis

650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
Study Design in Statistics01:15

Study Design in Statistics

9.9K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
9.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring deep learning methods for recognizing rare diseases and their clinical manifestations from texts.

BMC bioinformatics·2022
Same author

The RareDis corpus: A corpus annotated with rare diseases, their signs and symptoms.

Journal of biomedical informatics·2021
Same author

Comparing deep learning architectures for sentiment analysis on drug reviews.

Journal of biomedical informatics·2020
Same author

A two-stage deep learning approach for extracting entities and relationships from medical texts.

Journal of biomedical informatics·2019
Same author

Predicting of anaphylaxis in big data EMR by exploring machine learning approaches.

Journal of biomedical informatics·2018
Same author

Evaluation of pooling operations in convolutional architectures for drug-drug interaction extraction.

BMC bioinformatics·2018

Related Experiment Video

Updated: Jan 19, 2026

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.3K

Cohort selection for clinical trials using deep learning models.

Isabel Segura-Bedmar1, Pablo Raez1

  • 1Department of Computer Science and Engineering, Universidad Carlos III de Madrid, Leganés, Spain.

Journal of the American Medical Informatics Association : JAMIA
|September 19, 2019
PubMed
Summary

Deep learning models, including recurrent neural networks (RNNs), show promise for automated clinical trial cohort selection. These natural language processing techniques can significantly reduce trial costs and time by identifying eligible patients with minimal human intervention.

Keywords:
cohort selectionconvolutional neural networkdeep learningmultilabel text classificationrecurrent neural network

Related Experiment Videos

Last Updated: Jan 19, 2026

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.3K

Area of Science:

  • Medical Informatics
  • Artificial Intelligence
  • Clinical Trial Management

Background:

  • Automated patient identification for clinical trials is crucial for efficient research.
  • Natural language processing (NLP) and deep learning offer potential solutions for complex cohort selection tasks.
  • The 2018 n2c2 shared task focused on evaluating deep learning for clinical trial cohort selection.

Purpose of the Study:

  • To evaluate the effectiveness of various deep learning architectures for automated clinical trial cohort selection.
  • To assess the contribution of NLP and deep learning in identifying patients meeting clinical trial criteria.
  • To investigate the impact of a fully connected feedforward layer on deep learning model performance.

Main Methods:

  • Formulated cohort selection as a multilabeling problem.
  • Explored deep learning architectures: Convolutional Neural Networks (CNNs), Recurrent Neural Networks (RNNs), and hybrid CNN-RNN models.
  • Investigated the effect of a fully connected feedforward layer on model performance.

Main Results:

  • Recurrent Neural Network (RNN) and hybrid CNN-RNN models achieved the best performance.
  • The addition of a fully connected feedforward layer generally improved results across architectures, with an exception in the hybrid model.
  • Performance gains were observed despite the limited dataset size.

Conclusions:

  • Deep learning methods demonstrate potential for effective feature learning in cohort selection.
  • These models can serve as a preliminary filter for clinical trial cohort identification.
  • Implementing deep learning can substantially decrease the time and cost associated with clinical trials.